IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 27 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,621,783 | +2.3% | 2,756,000 | 0.0% | 2.46% | +6.4% |
| Q2 2023 | $2,563,224 | +1.0% | 2,756,000 | 0.0% | 2.31% | -4.0% |
| Q1 2023 | $2,537,097 | +122.4% | 2,756,000 | +119.4% | 2.41% | +89.1% |
| Q4 2022 | $1,140,574 | +0.4% | 1,256,000 | 0.0% | 1.27% | -14.4% |
| Q3 2022 | $1,136,000 | +3.0% | 1,256,000 | 0.0% | 1.49% | 0.0% |
| Q2 2022 | $1,103,000 | -2.0% | 1,256,000 | 0.0% | 1.49% | +13.9% |
| Q1 2022 | $1,126,000 | +47.2% | 1,256,000 | +146629.0% | 1.31% | +59.3% |
| Q4 2021 | $765,000 | -2.9% | 856 | 0.0% | 0.82% | -34.2% |
| Q3 2021 | $788,000 | -0.3% | 856 | 0.0% | 1.25% | +26.2% |
| Q2 2021 | $790,000 | +48.8% | 856 | -99.8% | 0.99% | +64.5% |
| Q1 2021 | $531,000 | +46.3% | 556,000 | +56.2% | 0.60% | +86.9% |
| Q4 2020 | $363,000 | – | 356,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penn Mutual Asset Management, LLC | 2,756,000 | $2,621,783 | 2.46% |
| Sonora Investment Management Group, LLC | 18,573,000 | $17,727,727 | 1.52% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,614,000 | $2,483,300 | 0.07% |
| Kohlberg Kravis Roberts & Co. L.P. | 510,000 | $487,713 | 0.02% |
| PINNACLE ASSOCIATES LTD | 280,000 | $267,154 | 0.01% |
| MACQUARIE GROUP LTD | 3,903,000 | $3,732,000 | 0.01% |
| HighTower Advisors, LLC | 2,453,000 | $2,355,000 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 2,500,000 | $2,357,500 | 0.00% |
| CITIGROUP INC | 1,754,000 | $1,668,580 | 0.00% |
| MORGAN STANLEY | 7,090,000 | $6,717,775 | 0.00% |